ACADIA PHARMACEUTICALS INC Annual Return On Equity in % from 2012 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Acadia Pharmaceuticals Inc quarterly/annual Return On Equity history and growth rate from 2012 to 2023.
  • Acadia Pharmaceuticals Inc Return On Equity for the quarter ending September 30, 2024 was 25.8 %.
  • Acadia Pharmaceuticals Inc annual Return On Equity for 2023 was -15.7 %, a 69% increase from 2022.
  • Acadia Pharmaceuticals Inc annual Return On Equity for 2022 was -50.7 %, a 70% decline from 2021.
  • Acadia Pharmaceuticals Inc annual Return On Equity for 2021 was -29.8 %, a 31.7% increase from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -15.7 +35 +69% Jan 1, 2023 Dec 31, 2023
2022 -50.7 -20.9 -70% Jan 1, 2022 Dec 31, 2022
2021 -29.8 +13.8 +31.7% Jan 1, 2021 Dec 31, 2021
2020 -43.6 -0.74 -1.73% Jan 1, 2020 Dec 31, 2020
2019 -42.9 +34.3 +44.4% Jan 1, 2019 Dec 31, 2019
2018 -77.1 -4.12 -5.64% Jan 1, 2018 Dec 31, 2018
2017 -73 -17.4 -31.2% Jan 1, 2017 Dec 31, 2017
2016 -55.7 +12.3 +18.1% Jan 1, 2016 Dec 31, 2016
2015 -68 -40.7 -149% Jan 1, 2015 Dec 31, 2015
2014 -27.3 -2.96 -12.2% Jan 1, 2014 Dec 31, 2014
2013 -24.3 +38.4 +61.2% Jan 1, 2013 Dec 31, 2013
2012 -62.7 Jan 1, 2012 Dec 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.